Trials / Completed
CompletedNCT01356537
Home Therapy With VPRIV in Gaucher's Disease
Non Interventional Study of VPRIV® (Velaglucerase Alfa) Home Therapy in Patients With Gaucher's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to proof increasing patient satisfaction and preservation of quality of life in patients with Gaucher's Disease receiving their enzyme replacement therapy with VPRIV (Velaglucerase alfa)at their home setting compared to receiving the infusions at the clinic or at doctor's practice.
Conditions
Timeline
- Start date
- 2011-05-20
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
- First posted
- 2011-05-19
- Last updated
- 2021-03-17
Locations
11 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT01356537. Inclusion in this directory is not an endorsement.